Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
Granite Construction
GVA
$5.47B
| $29M | 0.06% |
526,460
+423,572
| +412% | +$22.5M |
|
452
AutoNation
AN
$6.45B
| $28.8M | 0.06% |
592,911
+469,920
| +382% | +$21.8M |
|
453
Lennox International
LII
$13.8B
| $28.8M | 0.06% |
187,882
+183,468
| +4,157% | +$28M |
|
454
McCormick & Company Non-Voting
MKC
$15.1B
| $28.7M | 0.06% |
614,860
+494,598
| +411% | +$23.1M |
|
455
Jabil
JBL
$31.9B
| $28.7M | 0.06% |
1,210,715
+693,475
| +134% | +$15.1M |
|
456
Fortune Brands Innovations
FBIN
$5.37B
| $28.6M | 0.06% |
626,959
+93,700
| +18% | +$4.42M |
|
|
ARRS
457
DELISTED
ARRIS International plc Ordinary Shares
ARRS
| $28.5M | 0.06% |
946,372
-321,324
| -25% | -$9.32M |
|
458
Rexford Industrial Realty
REXR
$8.4B
| $28.4M | 0.06% |
1,225,738
-65,935
| -5% | -$1.45M |
|
459
Exelixis
EXEL
$13.5B
| $28.3M | 0.06% |
1,899,564
+997,404
| +111% | +$14.4M |
|
|
ALXN
460
DELISTED
Alexion Pharmaceuticals
ALXN
| $28.1M | 0.06% |
229,311
-775,087
| -77% | -$94.8M |
|
461
Rithm Capital
RITM
$5.72B
| $28M | 0.06% |
1,782,900
-146,223
| -8% | -$2.16M |
|
462
Lam Research
LRCX
$388B
| $28M | 0.06% |
2,647,400
-80,550
| -3% | -$818K |
|
463
Waters Corp
WAT
$40.4B
| $28M | 0.06% |
207,988
+189,865
| +1,048% | +$27.1M |
|
464
Ares Capital
ARCC
$14.4B
| $27.8M | 0.06% |
1,688,666
-120,669
| -7% | -$1.9M |
|
465
Integra LifeSciences
IART
$1.3B
| $27.7M | 0.06% |
645,902
+505,006
| +358% | +$20.5M |
|
466
Smith & Nephew
SNN
$12.4B
| $27.5M | 0.06% |
914,005
+144,891
| +19% | +$4.26M |
|
|
SPNC
467
DELISTED
Spectranetics Corp
SPNC
| $27.5M | 0.06% |
1,121,614
-113,936
| -9% | -$2.68M |
|
468
Nasdaq
NDAQ
$55.2B
| $27.4M | 0.06% |
1,224,756
-351,603
| -22% | -$7.76M |
|
469
STAG Industrial
STAG
$7.14B
| $27.4M | 0.06% |
1,147,753
+557,318
| +94% | +$12.8M |
|
|
GWPH
470
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $27.4M | 0.06% |
244,980
+106,642
| +77% | +$12.8M |
|
|
PACW
471
DELISTED
PacWest Bancorp
PACW
| $27.4M | 0.06% |
502,467
+495,681
| +7,304% | +$24M |
|
472
Amphenol
APH
$192B
| $27.2M | 0.06% |
+1,616,580
| New | +$26.9M |
|
|
BPFH
473
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $27M | 0.06% |
1,633,316
+548,248
| +51% | +$7.94M |
|
474
Mettler-Toledo International
MTD
$28B
| $27M | 0.06% |
64,500
+58,275
| +936% | +$24.3M |
|
475
Puma Biotechnology
PBYI
$471M
| $26.9M | 0.06% |
875,718
+269,103
| +44% | +$11.6M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.